SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 7/28/2017 5:24:58 AM - Followers: 1341 - Board type: Free - Posts Today: 1

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
FDA Calendar
Recent Biotech Buyouts

Buyouts of Biotech Partners
Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#212709  Sticky Note Astellas/PFE terminate Xtandi program in breast cancer (all settings): DewDiligence 07/28/17 05:24:57 AM
#212708  Sticky Note TTPH sells 11.5M* shares @$6.50—an 18% discount to DewDiligence 07/27/17 10:05:33 PM
#212695  Sticky Note EGRX—What benefit would LLY gain by passing up DewDiligence 07/27/17 11:30:26 AM
#212687  Sticky Note AstraZeneca and Merck Establish Strategic Oncology Collaboration $2.4 maverick_1 07/27/17 09:20:53 AM
#212685  Sticky Note AstraZeneca Plunges After Setback in Crucial Lung-Cancer Drug maverick_1 07/27/17 07:00:22 AM
#212680  Sticky Note DVAX reuters summary / highlights from FDA's document dangerM 07/26/17 06:33:31 PM
#212709   Astellas/PFE terminate Xtandi program in breast cancer (all settings): DewDiligence 07/28/17 05:24:57 AM
#212708   TTPH sells 11.5M* shares @$6.50—an 18% discount to DewDiligence 07/27/17 10:05:33 PM
#212707   KBIO—>HGEN (Humanigen) effective 8/7/17: DewDiligence 07/27/17 06:33:05 PM
#212706   AZN WRAPUP: AstraZeneca-Mystic-failure-shows-the-peril-of-going-all-in maverick_1 07/27/17 06:08:07 PM
#212705   A humbling setback for an immune-revving cancer therapy Titan V 07/27/17 04:01:16 PM
#212704   TYMI: think this old article sort of points swampboots 07/27/17 03:53:01 PM
#212703   AZN—(lost in MYSTIC fallout)—reports positive phase-3 for Tagrisso DewDiligence 07/27/17 02:30:05 PM
#212702   (MNTA)—B-I starts switching study for Humira FoB: DewDiligence 07/27/17 02:03:39 PM
#212701   TYMI +44%(!) on uplisting to Nasdaq: DewDiligence 07/27/17 02:01:16 PM
#212700   IPCI -45% on yesterday’s negative advisory-panel vote: DewDiligence 07/27/17 01:58:03 PM
#212699   SNNA IPOs 4.98M* shares @$15.00: DewDiligence 07/27/17 01:41:56 PM
#212698   FDA is not “playing tricks” with EGRX. FDA DewDiligence 07/27/17 11:58:45 AM
#212697   EGRX is perfectly fine if FDA tell EGRX GD 07/27/17 11:40:59 AM
#212696   IMO, FDA played dirty on EGRX with EHS indication Bickema 07/27/17 11:35:54 AM
#212695   EGRX—What benefit would LLY gain by passing up DewDiligence 07/27/17 11:30:26 AM
#212694   IMO, FDA played dirty on EGRX with EHS GD 07/27/17 10:50:50 AM
#212692   I wouldn't go that far (unless you were JohnWayne 07/27/17 10:17:17 AM
#212691   "Seems like a better deal for AZN than biotech_researcher 07/27/17 10:14:21 AM
#212690   AZN/MRK: this caught me by surprise. I guess JohnWayne 07/27/17 10:12:31 AM
#212689   AZN trading ~15% below what PFE offered in DewDiligence 07/27/17 10:02:21 AM
#212688   Key partner cuts ties with brash biotech startup Titan V 07/27/17 10:01:04 AM
#212687   AstraZeneca and Merck Establish Strategic Oncology Collaboration $2.4 maverick_1 07/27/17 09:20:53 AM
#212686   Any interest in AstraZeneca after the drop? A biotech_researcher 07/27/17 07:39:58 AM
#212685   AstraZeneca Plunges After Setback in Crucial Lung-Cancer Drug maverick_1 07/27/17 07:00:22 AM
#212684   Good question. LLY didn't sue upon notification of Bickema 07/26/17 10:54:26 PM
#212683   EGRX—...do you think Eli Lilly will file a DewDiligence 07/26/17 07:22:26 PM
#212682   EGRX - moving on, do you think Eli Bickema 07/26/17 06:55:21 PM
#212681   TTPH public offering: LOL, just signed back in apljack 07/26/17 06:53:21 PM
#212680   DVAX reuters summary / highlights from FDA's document dangerM 07/26/17 06:33:31 PM
#212679   RE: Madrigal news, MDGL. jmarce 07/26/17 06:15:38 PM
#212678   TTPH selling $69M of stock on unspecified terms: DewDiligence 07/26/17 04:55:33 PM
#212677   GILD 2Q17 CC slides: DewDiligence 07/26/17 04:22:34 PM
#212676   Although GILD’s HCV sales rose 11% QoQ, this DewDiligence 07/26/17 04:20:38 PM
#212675   >>5 out of 997 on 4mg arm during biomaven0 07/26/17 04:13:04 PM
#212674   GILD reports 2Q17 results—$2.9B HCV sales beat consensus forecast: DewDiligence 07/26/17 04:07:35 PM
#212673   DVAX not enough time to read in detail dangerM 07/26/17 03:58:48 PM
#212672   IMDZ I think they are close Whalatane 07/26/17 03:53:52 PM
#212671   IMDZ Bladerunner ...I have had a small position bladerunner1717 07/26/17 03:31:07 PM
#212670   IMDZ Bladerunner ...I have had a Whalatane 07/26/17 03:16:03 PM
#212669   EGRX—Thanks for remembering by skepticism vis-á-vis the Ryanodex DewDiligence 07/26/17 03:06:21 PM
#212668   Dew you called this, I remember you were Bickema 07/26/17 02:45:20 PM
#212667   Checkpoint Inhibitors Moving Ahead in Breast Cancer Titan V 07/26/17 02:31:55 PM
#212666   EVGN inks corn-seed collaboration with DD, but no DewDiligence 07/26/17 01:41:02 PM
#212665   IMDZ up 8%, hits new 52-week high. bladerunner1717 07/26/17 01:31:04 PM
#212664   EGRX resumes trading down 21% (eom). DewDiligence 07/26/17 01:01:51 PM
#212663   EGRX receives CRL for Ryanodex in heatstroke: DewDiligence 07/26/17 12:36:08 PM
#212662   CGEN -5% as Bayer dumps 1of2 I-O programs: DewDiligence 07/26/17 12:17:35 PM
#212661   DVAX +8% on Heplisav briefing docs for upcoming DewDiligence 07/26/17 12:15:16 PM
#212660   TTPH: "how long do you think it will apljack 07/26/17 12:15:13 PM
#212659   GSK terminating/divesting 13 clinical/20 preclinical programs—see slide #17 DewDiligence 07/26/17 11:40:21 AM
PostSubject